Moreover, a significantly higher m6A modification level was found in liver metastatic CRC than in non-metastatic CRC, suggesting that m6A modification was required to boost the BACE1-AS level in liver metastatic CRC (Fig. 1K-L). The gene discussed is BACE1; the disease is colorectal carcinoma.